Phase I trial of OTS11101, an anti‐angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor

類似資料

• Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors
  著者:: Okamoto, Isamu, 等
  出版事項: (2012)
• MET amplification as a potential therapeutic target in gastric cancer
  著者:: Kawakami, Hisato, 等
  出版事項: (2012)
• Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
  著者:: Hayashi, Hidetoshi, 等
  出版事項: (2011)
• Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI
  著者:: Yonesaka, Kimio, 等
  出版事項: (2019)
• A Case of Pulmonary Tumor Thrombotic Microangiopathy Suggested by the Presence of Tumor Cells in Peripheral Blood
  著者:: Kawanaka, Yusuke, 等
  出版事項: (2020)